PropertyValue
?:abstract
  • WATERLIT Abstract: Developers and funders are laying the groundwork for efficacy trials, but only a handful of vaccines are likely to make the cut
?:creator
?:journal
  • Health_Systems_Trust_Bulletin
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Scores of coronavirus vaccines are in competition — how will scientists choose the best?
?:type
?:who_covidence_id
  • #1033927
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3157661_T043>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3157661_T043>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all